Services

Meet NHS, EU Payers &
C-Suite Decision-Makers

We understand the importance of establishing meaningful connections with influential decision-makers to drive your business growth and strategic initiatives. With over 15 years of experience in connecting professionals with top-level executives, we offer unparalleled access and insights into Europe’s healthcare business landscape.

Strategic Engagement for Reimbursement, Procurement, and HTA Success

At Odelle Technology, we connect innovators with the people who make the real decisions — NHS commissioners, EU payers, health insurers, HTA advisors, and procurement leaders. These are the individuals who determine whether a new health technology will be adopted, reimbursed, or scaled.

Why These Meetings Matter

Too many technologies succeed in pilots but never reach full adoption. Engaging with payers and commissioners early helps you:

• Validate your pricing and economic model

• Understand coding or pathway misalignments

• Refine HTA submissions and BIA assumptions

• Test adoption risk with actual stakeholders

• Strengthen investor and procurement readiness

Who Can You Meet?

We organise interviews and strategic sessions with:

United Kingdom

NHS Integrated Care Systems (ICS), CFOs, NICE assessors, AHSNs

France

CNEDiMTS experts, PECAN evaluators, ARS decision-makers

Germany

Statutory health insurers (GKV), NUB stakeholders, OPS/EBM coders

Spain

Regional HTA bodies (CatSalut, SERMAS, Andalusia), Consorcio procurement leads

Italy

AIFA, Agenas, regional procurement managers (Lombardy, Emilia-Romagna, Veneto)

Sweden & Belgium

TLV, KCE, RIZIV-Mutualités, hospital-based payers

Austria, Portugal, Ireland

Hospital procurement and payer groups across regional health authorities

what we offer

Targeted Stakeholder Recruitment

NHS commissioners, CFOs, EU payers, and HTA stakeholders
GDPR-compliant recruitment with consent and incentives if appropriate

Interview & Research Techniques

1:1 depth interviews (virtual or in-person)
Co-creation workshops and value testing
Cognitive interviews and comparator testing
Payer focus groups by country or region
Exit interviews following HTA rejection or pilot completion
Journey mapping and care pathway validation
Observational research (pilot or early implementation studies)

Full Research Support

Custom screeners and discussion guides
Scheduling, logistics, transcription, and moderation
Thematic analysis and executive-level summary reports
Online presentation of insights to boards, pricing teams, or investors

Use Cases

Pre-NICE HTE or Early Value Assessment
PECAN readiness testing in France
LPPR or CNEDiMTS submission strategy
DiGA or NUB dossier development in Germany
Regional payer adoption planning in Spain or Italy
Validation of cost-consequence assumptions before HTA
Procurement and pricing alignment for ICS/NHS tendering

How It’s Delivered

Stakeholder recruitment (commissioners, payers, HTA advisors)
Interview moderation and insight synthesis
Presentation of findings with actionable recommendations
Post-meeting strategy support and follow-up

Trusted by Innovators Across Europe

Our work is grounded in payer logic, reimbursement system science, and HTA methodology — not generic market research. We align all engagements with:

NICE HTA Methods & BIA Templates
PECAN and Forfait Innovation guidance (France)
EBM, OPS, and NUB rules (Germany)
DiGA and LPPR dossier evidence requirements
KCE, TLV, HAS, ZIN and EU HTA21 frameworks

Ready to Speak with Decision-Makers?

Whether you’re planning an HTA submission, building a DiGA dossier, or validating pricing for the NHS, we help you engage the right stakeholders at the right time.

Testimonials

With over 65 years combined experience, we have a long track record of delivering timely solutions for our clients.

Odelle Technology’s voluntary support was pivotal in securing two NICE guidelines and establishing new HRG codes for Deep Brain Stimulation (DBS) within the NHS. They didn’t just navigate the complexities of regulatory and economic frameworks—they energised my team of scientists, bringing their expertise to life and amplifying the impact of our work. Their ability to connect our efforts with commissioners and NHSE made DBS more accessible to patients across the UK and further. Their dedication and collaborative spirit were transformative, and I would wholeheartedly recommend them as a team of experts in getting things done in advancing healthcare innovation.

Professor of Neurosurgery

Founder of Oxford Functional Neurosurgery
Consultant Neurosurgeon
Oxford University Hospitals NHS Foundation Trust

We chose to work with Steven on KOL interviews and payer perspectives after speaking to a few firms. Steven is extremely friendly, kind and a great communicator. In addition to these, he understood our situation as a start up and tailored a custom solution for us. Steven's passion makes him a natural when you need someone to speak to people and gain insights for your product. I would recommend Steven and look forward to continue our work together.

Anand Nandakumar Ph.D

CEO, Founder
TherageniX

Steven has done an amazing job to help support EyeYon's commercial efforts in Europe, which has allowed better access to EyeYon's products in major EU markets.

Charles Holmes

Chief Commercial Officer
EyeYon Medical

It’s been a great experience working alongside the team at Odelle, particularly when it comes to emerging trends. The expertise and insight that the team have, coupled with their adaptability has helped us to move the needle quickly on our market access strategy, in line with market demands.

Chris Gray

European Market Access Manager
CMR Surgical

Steven has amazing medical device contacts throughout the UK, Europe and into the US. He has an excellent understanding of the complex way in which the medical device system works. He also understands the re-imbursement processes in the UK and Europe. He is intelligent, hard working, honest and deeply invested in medical device technology and the connections which bring these technologies to market. He is a genuine facilitator and cares about outcomes and results.

Professor Rob Philips

Executive Chairman, Chief Executive Officer and Chief Scientist
USCOM

Odelle developed a value analysis tool for our new and disruptive technology in the breast cancer pathway, which allows us to work hand in hand with our customers to accurately reflect individual hospital practice in country specific healthcare systems. Odelle showed a real desire to understand our business and our objectives; they delivered to our brief, on time, on budget and coupled this with first class communication.

Amanda Durman

Vice President
Merit Oncology, EMEA
Merit Medical Systems Inc.

Odelle were invaluable in securing several procedural clinical HRG codes for interventional cardiology in the United Kingdom. These have facilitated the greatest adoption of three lifesaving technologies that have enabled many thousand of live to be saved. Their intelligence and superb planning was something we in the British Cardiovascular Society are immensely grateful for.

Professor Anthony Gershlick

University of Leicester and University Hospitals of Leicester NHS Trust

Excellent insights and deep understanding of the project we worked on. Spent time to really understand our needs which resulted in a great set of strategic suggestions to the company. Highly recommend.

Steve Bell

Chief Commercial Officer
CMR Surgical

I have personally worked with Steven for a number of years. Steven’s insight, breadth of knowledge, intelligence and passionate sense of purpose are a huge asset to any project. In particular innovation adoption, tech incubation, regulatory frameworks globally and reimbursement thinking. And, he is a good man!

Simon Tarry

Managing Director
Smith & Nephew UKI Nordics

I have worked with Steven many times for numerous clients in various verticals and always find his energy and work ethic endless, his network unmatched, and his sense of humor priceless. If you are looking to launch an innovative MedTech product and/or service into EMEA look no further Steven will get you connected, validated, partnered and capturing market share faster than anyone I know!

Stephen Wilson

Sr. Director, Global Strategic Innovation
Hologic, Inc.

Steven is an extremely able individual that really understands the healthcare and technology sector better than anyone else who I have ever come across. He makes it a priority of his to not only understand his clients but also his customers and as such its a pleasure doing business with him. Whether its market access, new technologies, generating opportunities out of thin air and merely taking time to think about the future then Steven is a star. Not only that but he makes time for YOU which shows how unselfish he is and how he invests his time in others. Make the time to get to know Steven and you will never regret it!

Martin Wakeley

Chairman of Clinical Commissioning Group
NHS, United Kingdom

Steven has assisted me with European business development and product introduction on multiple occasions since 2014. He is an amazing networker resulting in him being the most well connected person I know. He opens doors in health systems, partners, and distributors resulting in win-win collaborations, and always does it in a pleasant and fun way. Great to work with. If you are looking at taking a product through clinical validation and launching in the EMEA market, Steven is the one person you have to talk to.

Stewart Barlett

CEO
Ferronova

Our clients

Since our establishment, we have worked with a number of industry-leading clients, working to provide an efficient, successful service that delivers the best possible results for you. Some of these clients include:

+44 (0) 7804 623 339

Unit 1-2
Field View Business Park
Bicester
UNITED KINGDOM
OX27 7SG

15 Rue de President Roosevelt
Pons
FRANCE
17800

Meet NHS, EU Payers &C-Suite Decision-Makers